A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced injectables.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

And as mentioned, weight loss is an off-label use. Other brand names for semaglutide you might have heard of include Wegovy (a higher-dose semaglutide injection FDA-approved for weight loss ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

DeBenedetto, now 43, tells me she's been prediabetic since her 20s, and after going through hormone injections with IVF ...

The convenience of GetSimpli Oral Semaglutide cannot be overstated. Unlike traditional weight loss medications that often require painful injections, this product comes in a user-friendly ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...